Siegfried reported H1 2012 sales of CHF178.7m up 2.9% on 2011 and profits rose 29% to CHF40.1m. The company said that sales of drug products rose markedly after the launch of new drugs in the first half year, however it's drug substance business passed lower costs for raw materials on to customers.
In-pharma Technologist
Thursday 30 August 2012
Sales rise for Siegfried in H1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment